Grainger SDS Lookup

FLUOROCHEMICALS
ARKEMA INC.
2000 MARKET STREET
PHILADELPHIA, PA 19103

INFORMATION TELEPHONE NUMBERS:
PHONE NUMBER: 800-245-5858
AVAILABLE HRS: 8:00 AM - 5:30 PM (EASTERN)

EMERGENCY PHONE NUMBERS:

CHEMTREC: (800) 424-9300 (24HRS) OR (703) 527-3887

MEDICAL:
ROCKY MOUNTAIN POISON CONTROL CENTER: (866) 767-5089 (24HRS)

PRODUCT INFORMATION:

PRODUCT NAME: FORANE (R) 401B

PRODUCT SYNONYM(S):

CHEMICAL FAMILY: HYDROCHLOROFLUOROCARBON / HYDROFLUOROCARBON MIXTURE

CHEMICAL FORMULA: MIXTURE

CHEMICAL NAME:
CHLORODIFLUOROMETHANE (HCFC-22) / DIFLUOROETHANE (HFC-152A)/
2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (HCFC-124)

EPA REG NUM:

PRODUCT USE: REFRIGERANT

2 COMPOSITION / INFORMATION ON INGREDIENTS

INGREDIENT NAME                     CAS REGISTRY NUMBER  TYPICAL %   OSHA

CHLORODIFLUOROMETHANE (HCFC-22)       75-45-6            61% BY WT.  Y

1,1-DIFLUOROETHANE (HFC-152A)         75-37-6            11% BY WT.  Y

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE  2837-89-0            28% BY WT.  Y
(HCFC-124)

THE SUBSTANCE(S) MARKED WITH A "Y" IN THE OSHA COLUMN, ARE IDENTIFIED AS
HAZARDOUS CHEMICALS ACCORDING TO THE CRITERIA OF THE OSHA HAZARD
COMMUNICATION STANDARD (29 CFR 1910.1200)

THIS MATERIAL IS CLASSIFIED AS HAZARDOUS UNDER FEDERAL OSHA REGULATION.

THE COMPONENTS OF THIS PRODUCT ARE ALL ON THE TSCA INVENTORY LIST.

3 HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW:
COLORLESS LIQUIFIED GAS WITH FAINT ETHER ODOR.

WARNING!

LIQUID AND GAS UNDER PRESSURE, OVERHEATING AND OVERPRESSURIZING MAY CAUSE
GAS RELEASE OR VIOLENT CYLINDER BURSTING. MAY DECOMPOSE ON CONTACT WITH
FLAMES OR EXTREMELY HOT METAL SURFACES TO PRODUCE TOXIC AND CORROSIVE
PRODUCTS. VAPOR REDUCES OXYGEN AVAILABLE FOR BREATHING AND IS HEAVIER THAN
AIR. HARMFUL IF INHALED AND MAY CAUSE HEART IRREGULARITIES,
UNCONSCIOUSNESS OR DEATH. LIQUID CONTACT WITH EYES OR SKIN MAY CAUSE
FROSTBITE.

POTENTIAL HEALTH EFFECTS:
SKIN CONTACT AND INHALATION ARE EXPECTED TO BE THE PRIMARY ROUTES OF
OCCUPATIONAL EXPOSURE TO THIS MATERIAL. AS WITH MOST LIQUEFIED GASES,
CONTACT WITH THE RAPIDLY VOLATILIZING LIQUID CAN CAUSE FROSTBITE TO ANY
TISSUE. HIGH VAPOR CONCENTRATIONS ARE IRRITATING TO THE EYES AND
RESPIRATORY TRACT AND MAY RESULT IN CENTRAL NERVOUS SYSTEM (CNS) EFFECTS
SUCH AS HEADACHE, DIZZINESS, DROWSINESS AND, IN SEVERE EXPOSURE, LOSS OF
CONSCIOUSNESS AND DEATH. THE DENSE VAPOR OF THIS MATERIAL MAY REDUCE THE
AVAILABLE OXYGEN FOR BREATHING. PROLONGED EXPOSURE TO AN OXYGEN-DEFICIENT
ATMOSPHERE MAY BE FATAL. INHALATION MAY CAUSE AN INCREASE IN THE
SENSITIVITY OF THE HEART TO ADRENALINE, WHICH COULD RESULT IN IRREGULAR OR
RAPID HEARTBEATS. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE TO THIS
MATERIAL INCLUDE HEART DISEASE OR COMPROMISED HEART FUNCTION.

4 FIRST AID MEASURES

IF IN EYES, IMMEDIATELY FLUSH WITH PLENTY OF WATER. GET MEDICAL ATTENTION
IF IRRITATION PERSISTS.

IF ON SKIN, FLUSH EXPOSED SKIN WITH LUKEWARM WATER (NOT HOT), OR USE OTHER
MEANS TO WARM SKIN SLOWLY. GET MEDICAL ATTENTION IF FROSTBITTEN BY LIQUID
OR IF IRRITATION OCCURS.

IF SWALLOWED, NOT APPLICABLE - PRODUCT IS A GAS AT AMBIENT TEMPERATURES.

IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING, GIVE ARTIFICIAL
RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN. GET MEDICAL
ATTENTION. DO NOT GIVE ADRENALINE, EPINEPHRIN OR SIMILAR DRUGS FOLLOWING
EXPOSURE TO THIS PRODUCT.

5 FIRE FIGHTING MEASURES

FIRE AND EXPLOSIVE PROPERTIES:

AUTO-IGNITION TEMPERATURE: 1265 F / 685 C

FLASH POINT: NA - GAS
FLASH POINT METHOD:

FLAMMABLE LIMITS:
UPPER: NA
LOWER: NA

EXTINGUISHING MEDIA:
USE EXTINGUISHING MEDIA APPROPRIATE TO SURROUNDING FIRE CONDITIONS.

FIRE FIGHTING INSTRUCTIONS:
STOP THE FLOW OF GAS IF POSSIBLE. USE WATER SPRAY ON PERSON MAKING
SHUT-OFF. FIRE FIGHTERS AND OTHERS WHO MAY BE EXPOSED TO PRODUCTS OF
COMBUSTION SHOULD WEAR FULL FIRE FIGHTING TURN OUT GEAR (FULL BUNKER GEAR)
AND SELF-CONTAINED BREATHING APPARATUS (PRESSURE DEMAND NIOSH APPROVED OR
EQUIVALENT). FIRE FIGHTING EQUIPMENT SHOULD BE THOROUGHLY DECONTAMINATED
AFTER USE.

FIRE AND EXPLOSION HAZARDS:
MAY DECOMPOSE ON CONTACT WITH FLAMES OR EXTREMELY HOT METAL SURFACES TO
PRODUCE TOXIC AND CORROSIVE PRODUCTS. LIQUID AND GAS UNDER PRESSURE,
OVERHEATING OR OVERPRESSURIZING MAY CAUSE GAS RELEASE AND/OR VIOLENT
CYLINDER BURSTING. CONTAINER MAY EXPLODE IF HEATED DUE TO RESULTING
PRESSURE RISE. SOME MIXTURES OF HCFCS AND/OR HFCS, AND AIR OR OXYGEN MAY
BE COMBUSTIBLE IF PRESSURIZED AND EXPOSED TO EXTREME HEAT OR FLAME.

6 ACCIDENTAL RELEASE MEASURES

IN CASE OF SPILL OR LEAK:
USE HALOGEN LEAK DETECTOR OR OTHER SUITABLE MEANS TO LOCATE LEAKS OR CHECK
ATMOSPHERE. KEEP UPWIND. EVACUATE ENCLOSED SPACES AND DISPERSE GAS WITH
FLOOR-LEVEL FORCED-AIR VENTILATION. EXHAUST VAPORS OUTDOORS. DO NOT SMOKE
OR OPERATE INTERNAL COMBUSTION ENGINES. REMOVE FLAMES AND HEATING
ELEMENTS.

7 HANDLING AND STORAGE

HANDLING:
AVOID BREATHING GAS. AVOID CONTACT WITH EYES, SKIN AND CLOTHING. KEEP
CONTAINER CLOSED. USE ONLY WITH ADEQUATE VENTILATION. DO NOT ENTER
CONFINED SPACES UNLESS ADEQUATELY VENTILATED.

STORAGE:
DO NOT APPLY DIRECT FLAME TO CYLINDER. DO NOT STORE CYLINDER IN DIRECT SUN
OR EXPOSE IT TO HEAT ABOVE 120 F. DO NOT DROP OR REFILL THIS CYLINDER.
KEEP AWAY FROM HEAT, SPARKS AND FLAMES.

8 EXPOSURE CONTROLS / PERSONAL PROTECTION

ENGINEERING CONTROLS:
INVESTIGATE ENGINEERING TECHNIQUES TO REDUCE EXPOSURES BELOW AIRBORNE
EXPOSURE LIMITS. PROVIDE VENTILATION IF NECESSARY TO CONTROL EXPOSURE
LEVELS BELOW AIRBORNE EXPOSURE LIMITS (SEE BELOW). IF PRACTICAL, USE LOCAL
MECHANICAL EXHAUST VENTILATION AT SOURCES OF AIR CONTAMINATION SUCH AS
OPEN PROCESS EQUIPMENT.

EYE / FACE PROTECTION:
WHERE THERE IS POTENTIAL FOR EYE CONTACT, WEAR CHEMICAL GOGGLES AND HAVE
EYE FLUSHING EQUIPMENT AVAILABLE.

SKIN PROTECTION:
WEAR APPROPRIATE CHEMICAL RESISTANT PROTECTIVE CLOTHING AND CHEMICAL
RESISTANT GLOVES TO PREVENT SKIN CONTACT. CONSULT GLOVE MANUFACTURER TO
DETERMINE APPROPRIATE TYPE GLOVE MATERIAL FOR GIVEN APPLICATION. RINSE
CONTAMINATED SKIN PROMPTLY. WASH CONTAMINATED CLOTHING AND CLEAN
PROTECTIVE EQUIPMENT BEFORE REUSE. WASH SKIN THOROUGHLY AFTER HANDLING.

RESPIRATORY PROTECTION:
AVOID BREATHING GAS. WHEN AIRBORNE EXPOSURE LIMITS ARE EXCEEDED (SEE
BELOW), USE NIOSH APPROVED RESPIRATORY PROTECTION EQUIPMENT APPROPRIATE TO
THE MATERIAL AND/OR ITS COMPONENTS (FULL FACEPIECE RECOMMENDED). CONSULT
RESPIRATOR MANUFACTURER TO DETERMINE APPROPRIATE TYPE EQUIPMENT FOR A
GIVEN APPLICATION. OBSERVE RESPIRATOR USE LIMITATIONS SPECIFIED BY NIOSH
OR THE MANUFACTURER. FOR EMERGENCY AND OTHER CONDITIONS WHERE EXPOSURE
LIMIT MAY BE SIGNIFICANTLY EXCEEDED, USE AN APPROVED FULL FACE
POSITIVE-PRESSURE, SELF-CONTAINED BREATHING APPARATUS OR POSITIVE-PRESSURE
AIRLINE WITH AUXILIARY SELF-CONTAINED AIR SUPPLY. RESPIRATORY PROTECTION
PROGRAMS MUST COMPLY WITH 29 CFR SUBSECTION 1910.134.

AIRBORNE EXPOSURE GUIDELINES FOR INGREDIENTS:

EXPOSURE LIMIT                                   VALUE

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (HCFC-124):

WEEL TWA                                         1000 PPM

CHLORODIFLUOROMETHANE (HCFC-22):

ACGIH TWA                                        1000 PPM
                                                 3540 MG/M3

1,1-DIFLUOROETHANE (HFC-152A):

WEEL TWA                                         2700 MG/M3 (1000 PPM)

ONLY THOSE COMPONENTS WITH EXPOSURE LIMITS ARE PRINTED IN THIS SECTION.

SKIN CONTACT LIMITS DESIGNATED WITH A "Y" ABOVE HAVE SKIN CONTACT EFFECT.
AIR SAMPLING ALONE IS INSUFFICIENT TO ACCURATELY QUANTITATE EXPOSURE.
MEASURES TO PREVENT SIGNIFICANT CUTANEOUS ABSORPTION MAY BE REQUIRED.

ACGIH SENSITIZER DESIGNATOR WITH A VALUE OF "Y" ABOVE MEANS THAT EXPOSURE
TO THIS MATERIAL MAY CAUSE ALLERGIC REACTIONS.

WEEL-AIHA SENSITIZER DESIGNATOR WITH A VALUE OF "Y" ABOVE MEANS THAT
EXPOSURE TO THIS MATERIAL MAY CAUSE ALLERGIC SKIN REACTIONS.

9 PHYSICAL AND CHEMICAL PROPERTIES

APPEARANCE/ODOR: COLORLESS LIQUIFIED GAS WITH FAINT ETHER ODOR.

pH: NE

SPECIFIC GRAVITY: 1.193 G/CM3 @ 25 C / 77 F

VAPOR PRESSURE: 118.8 PSIA @ 25 C/77 F

VAPOR DENSITY: 3.2 @ 25 C / 77 F

MELTING POINT: NA

FREEZING POINT: NE

BOILING POINT: -34.6 C (-30.3 F)

SOLUBILITY IN WATER: NEGLIGIBLE

EVAPORATION RATE: >1 (CC 14=1.0)

PERCENT VOLATILE: 100

10 STABILITY AND REACTIVITY

STABILITY:
THIS MATERIAL IS CHEMICALLY STABLE UNDER SPECIFIED CONDITIONS OR STORAGE,
SHIPMENT AND/OR USE. SEE HANDLING AND STORAGE SECTION OF THIS MSDS FOR
SPECIFIED CONDITIONS.

INCOMPATIBILITY:
AVOID CONTACT WITH STRONG ALKALI OR ALKALINE EARTH METALS, FINELY POWDERED
METALS SUCH AS ALUMINUM, MAGNESIUM OR ZINC AND STRONG OXIDIZERS, SINCE
THEY MAY REACT OR ACCELERATE DECOMPOSITION.

HAZARDOUS DECOMPOSITION PRODUCTS:
THERMAL DECOMPOSITION PRODUCTS INCLUDE HYDROGEN FLUORIDE, HYDROGEN
CHLORIDE, CARBON MONOXIDE, CARBON DIOXIDE AND CHLORINE.

11 TOXICOLOGICAL INFORMATION

TOXICOLOGICAL INFORMATION:

CHLORODIFLUOROMETHANE:
SEVERAL ACCIDENTAL DEATHS HAVE BEEN ASSOCIATED WITH EXPOSURE TO THIS
MATERIAL OR MIXTURES WITH OTHER FLUOROCARBONS. DEATH WAS GENERALLY
ATTRIBUTED TO OXYGEN DEFICIENCY. MICROSCOPIC EXAMINATION OF THE TISSUES OF
SOME OF THE VICTIMS SHOWED EFFECTS ON THE LUNGS AND FATTY DEPOSITS IN
LIVER CELLS. AN INCREASE IN THE INCIDENCE OF HEART PALPITATIONS HAS BEEN
CLAIMED BY INDIVIDUALS OCCUPATIONALLY EXPOSED. MONITORING OF WORKERS
DURING OCCUPATIONAL EXPOSURE SHOWED NO CONNECTION TO EXPOSURE AND CARDIAC
ARRHYTHMIA OR NEUROLOGIC DISORDERS. OTHER EPIDEMIOLOGICAL STUDIES HAVE
REPORTED SIMILAR RESULTS. REPEATED SKIN APPLICATION OF A 10 SECOND SPRAY
CAUSED REDDENING AND SLIGHT SWELLING OF THE SKIN AND A DELAY IN HAIR
GROWTH.

NO SKIN ALLERGY WAS OBSERVED IN GUINEA PIGS FOLLOWING REPEATED EXPOSURE.
STUDIES WITH MICE, DOGS, RATS, RABBITS, CATS AND MONKEYS HAVE SHOWN THAT
INHALATION EXPOSURE CAN CAUSE CARDIAC ARRHYTHMIAS. INHALATION CAUSES AN
INITIAL STIMULATION AND THEN DEPRESSION OF THE CENTRAL NERVOUS SYSTEM
(CNS). SYMPTOMS IN ANIMALS INCLUDE LOSS OF EQUILIBRIUM, TREMORS,
CONVULSIONS AND NARCOSIS AND DEATH, USUALLY ATTRIBUTED TO ASPHYXIATION. AT
LEVELS THAT CAUSED ANESTHESIA, DOGS EXHIBITED CONVULSIONS. ACUTE EXPOSURE
BY INHALATION WAS FATAL TO RABBITS, ALSO CAUSING HEMORRHAGES AND EFFECTS
ON THE LIVER. FOLLOWING REPEATED INHALATION EXPOSURE, NO EFFECTS WERE
REPORTED IN GUINEA PIGS, DOGS AND CATS; MILD LIVER EFFECTS WERE REPORTED
IN RABBITS; AND, EFFECTS ON THE LUNGS, CNS, HEART, LIVER, KIDNEY, SPLEEN
WERE REPORTED IN RATS, MICE AND RABBITS. AN INCREASE IN MALIGNANT TUMORS
OF THE SALIVARY GLANDS WAS REPORTED IN MALE RATS BUT NOT IN FEMALE RATS OR
MICE OF EITHER SEX AFTER LONG-TERM INHALATION EXPOSURE. LONG-TERM ORAL
DOSING PRODUCED NO ADVERSE EFFECTS IN RATS. INHALATION EXPOSURE PRODUCED
NO ADVERSE EFFECTS ON MALE REPRODUCTIVE PERFORMANCE IN RATS AND MICE. EYE
MALFORMATIONS WERE REPORTED IN THE OFFSPRING OF RATS EXPOSED BY INHALATION
DURING PREGNANCY. IN RABBITS, RATS AND HUMANS, A SMALL PORTION OF INHALED
MATERIAL WAS DISTRIBUTED INTO THE BRAIN, HEART, LUNGS, LIVER, KIDNEYS AND
FAT. IT WAS RAPIDLY ELIMINATED FROM THE BODY IN THE INHALED AIR. NO
SIGNIFICANT METABOLISM OCCURS IN HUMANS OR RATS. THE RESULTS OF THE TESTS
FOR GENETIC CHANGES WERE MIXED.

SINGLE EXPOSURE (ACUTE) STUDIES INDICATE:

INHALATION - PRACTICALLY NON-TOXIC TO RATS (2 HR-LC50: 300,000 PPM)

EYE IRRITATION - SLIGHTLY IRRITATING TO RABBITS (5-30 SEC. EXPOSURE TO GAS
SPRAY)

SKIN IRRITATION - MODERATELY IRRITATING TO RABBITS (LIQUEFIED GAS WITH
PATCH APPLIED)

1,1-DIFLUOROETHANE (HFC-152A):
STUDIES OF WORKERS EXPOSED IN INDUSTRY OPERATIONS DID NOT INDICATE THAT
THIS MATERIAL CAUSES HEART ARRHYTHMIAS. ACUTE INHALATION EXPOSURE PRODUCED
SIGNS OF SEDATION AND HEART ARRHYTHMIAS IN RATS, BUT NO ADVERSE EFFECTS
WERE OBSERVED IN MICE OR MONKEYS. RATS DID NOT EXHIBIT INCREASED
SENSITIVITY TO CARDIAC EFFECTS AFTER CHEMICALLY INDUCED HEART INJURY, BUT
DID SHOW AN INCREASED SENSITIVITY AFTER CHEMICALLY INDUCED INJURY TO LUNG
ARTERIES. INHALATION, FOLLOWED BY INTRAVENOUS INJECTION OF EPINEPHRINE TO
SIMULATE STRESS REACTIONS, RESULTED IN CARDIAC SENSITIZATION IN DOGS.
FOLLOWING REPEATED INHALATION EXPOSURE, RESPIRATORY IRRITATION, SEDATION
AND AN INCREASE IN URINARY EXCRETION OF FLUORIDE WERE OBSERVED IN RATS.
EFFECTS ON NASAL TISSUE AND REVERSIBLE KIDNEY CHANGES WERE OBSERVED IN
RATS FOLLOWING LONG-TERM INHALATION, BUT NO INCREASE IN THE INCIDENCE OF
TUMORS WAS OBSERVED. NO BIRTH DEFECTS WERE NOTED IN THE OFFSPRING OF RATS
EXPOSED BY INHALATION DURING PREGNANCY. NO GENETIC CHANGES WERE OBSERVED
IN A TEST USING BACTERIA, BUT WERE OBSERVED IN A TEST USING HUMAN CELLS.

SINGLE EXPOSURE (ACUTE) STUDIES INDICATE:
INHALATION - PRACTICALLY NON-TOXIC TO RATS (4-HR LC50: 383,000 PPM)

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE:
ACUTE INHALATION OF HIGH CONCENTRATIONS HAS PRODUCED A RAPID ANESTHETIC
EFFECT IN MICE AND DOGS. INHALATION, FOLLOWED BY INTRAVENOUS INJECTION OF
EPINEPHRINE TO SIMULATE STRESS REACTIONS, RESULTED IN CARDIAC
SENSITIZATION IN DOGS. FOLLOWING REPEATED INHALATION EXPOSURE, DROWSINESS
AND LOSS OF COORDINATION WERE OBSERVED IN RATS (AT HIGH DOSE LEVELS) AND
SLIGHT CENTRAL NERVOUS SYSTEM EFFECTS AND MINOR BLOOD CHEMISTRY CHANGES
WERE OBSERVED IN RATS AND MICE. LONG-TERM INHALATION PRODUCED NO INCREASED
INCIDENCE OF TUMORS IN RATS. NO BIRTH DEFECTS WERE NOTED IN THE OFFSPRING
OF RATS OR RABBITS EXPOSED BY INHALATION DURING PREGNANCY, EVEN AT DOSAGES
WHICH PRODUCED ADVERSE EFFECTS IN THE MOTHER. NO GENETIC CHANGES WERE
OBSERVED IN TESTS USING BACTERIA, ANIMAL CELLS OR ANIMALS.

SINGLE EXPOSURE (ACUTE) STUDIES INDICATE:
INHALATION - PRACTICALLY NON-TOXIC TO RATS (4-HR LC50: 230,000 TO
300,000 PPM)

12 ECOLOGICAL INFORMATION

ECOTOXICOLOGICAL INFORMATION:

CHLORODIFLUOROMETHANE:
THE TOXICITY THRESHOLD FOR FISH IS 180 MG/L (24-HRS) AND FOR BACTERIA
UNDER ANAEROBIC CONDITIONS IS >400 MG/L (24-HRS). NO EFFECTS WERE REPORTED
ON THE GROWTH OF AEROBIC AND ANAEROBIC MICROORGANISMS OVER A 24 HOUR
PERIOD, INCLUDING GRAM-POSITIVE AND GRAM-NEGATIVE SPECIES, FROM EXPOSURE
TO A MEDIA THAT CONTAINED THIS MATERIAL AT 5 MG/ML.

CHEMICAL FATE INFORMATION:

CHLORODIFLUOROMETHANE:
THIS MATERIAL IS NOT READILY BIODEGRADABLE (0% AFTER 28-DAYS) AND IS
PRACTICALLY NOT BIOACCUMULABLE (LOG POW 1.08). IN AIR, IT HAS A HALF-LIFE
IN THE ATMOSPHERE OF 8.4 YEARS, AN OZONE DEPLETION POTENTIAL (ODP) OF
0.055, AND A HALOCARBON GLOBAL WARMING POTENTIAL (HGWP) OF 0.33. IT IS
MODERATELY ADSORBED IN SOILS AND SEDIMENTS (LOG KOC 1.8).

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE:
WHEN RELEASED INTO THE ENVIRONMENT, THIS MATERIAL MAY BE EXPECTED TO
PARTITION ALMOST EXCLUSIVELY INTO THE ATMOSPHERE. BIOACCUMULATION IS
CONSIDERED UNLIKELY (LOG POW 1.9-2.0). THIS MATERIAL IS NOT READILY
BIODEGRADABLE (2% AFTER 28-DAYS).

13 DISPOSAL CONSIDERATIONS

WASTE DISPOSAL:
RECOVER, RECLAIM OR RECYCLE WHEN PRACTICAL. DISPOSE OF IN ACCORDANCE WITH
FEDERAL, STATE AND LOCAL REGULATIONS.

NOTE:
CHEMICAL ADDITIONS TO, PROCESSING OF, OR OTHERWISE ALTERING THIS MATERIAL
MAY MAKE THIS WASTE MANAGEMENT INFORMATION INCOMPLETE, INACCURATE, OR
OTHERWISE INAPPROPRIATE. FURTHERMORE, STATE AND LOCAL WASTE DISPOSAL
REQUIREMENTS MAY BE MORE RESTRICTIVE OR OTHERWISE DIFFERENT FROM FEDERAL
LAWS AND REGULATIONS.

14 TRANSPORT INFORMATION

DOT NAME: LIQUEFIED GAS NOS

DOT TECHNICAL NAME: (CHLORODIFLUOROMETHANE, CHLOROTETRAFLUOROETHANE)

DOT HAZARD CLASS: 2.2

UN NUMBER: UN 3163

DOT PACKING GROUP:
PG: NA

RQ:

15 REGULATORY INFORMATION

HAZARD CATEGORIES UNDER CRITERIA OF SARA TITLE III RULES (40 CFR PART
370):
IMMEDIATE (ACUTE) HEALTH   (Y)
DELAYED (CHRONIC) HEALTH   (N)
FIRE                       (N)
REACTIVE                   (N)
SUDDEN RELEASE OF PRESSURE (Y)

THE COMPONENTS OF THIS PRODUCT ARE ALL ON THE TSCA INVENTORY LIST.

INGREDIENT RELATED REGULATORY INFORMATION:

SARA REPORTABLE QUANTITIES                       CERCLA RQ    SARA TPQ

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (HCFC-124)    NE

CHLORODIFLUOROMETHANE (HCFC-22)                  NE

1,1-DIFLUOROETHANE (HFC-152A)                    NE

SARA TITLE III, SECTION 313:
THIS PRODUCT DOES CONTAIN CHEMICAL(S) WHICH ARE DEFINED AS TOXIC CHEMICALS
UNDER AND SUBJECT TO THE REPORTING REQUIREMENTS OF, SECTION 313 OF TITLE
III OF THE SUPERFUND AMENDMENTS AND REAUTHORIZATION ACT OF 1986 AND 40 CFR
PART 372. SEE SECTION 2

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (HCFC-124)

CHLORODIFLUOROMETHANE (HCFC-22)

MASSACHUSETTS RIGHT TO KNOW:
THIS PRODUCT DOES CONTAIN THE FOLLOWING CHEMICALS(S), AS INDICATED BELOW,
CURRENTLY ON THE MASSACHUSETTS RIGHT TO KNOW SUBSTANCE LIST.

1,1-DIFLUOROETHANE (HFC-152A)

CHLORODIFLUOROMETHANE (HCFC-22)

NEW JERSEY RIGHT TO KNOW:
THIS PRODUCT DOES CONTAIN THE FOLLOWING CHEMICAL(S), AS INDICATED BELOW,
CURRENTLY ON THE NEW JERSEY RIGHT-TO-KNOW SUBSTANCES LIST.

1,1-DIFLUOROETHANE (HFC-152A)

2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (HCFC-124)

CHLORODIFLUOROMETHANE (HCFC-22)

PENNSYLVANIA ENVIRONMENTAL HAZARD:
THIS PRODUCT DOES CONTAIN THE FOLLOWING CHEMICAL(S), AS INDICATED BELOW,
CURRENTLY ON THE PENNSYLVANIA ENVIRONMENTAL HAZARD LIST.

CHLORODIFLUOROMETHANE (HCFC-22)

PENNSYLVANIA RIGHT TO KNOW:
THIS PRODUCT DOES CONTAIN THE FOLLOWING CHEMICAL(S), AS INDICATED BELOW,
CURRENTLY ON THE PENNSYLVANIA HAZARDOUS SUBSTANCE LIST.

CHLORODIFLUOROMETHANE (HCFC-22)

16 OTHER INFORMATION

REVISION INFORMATION:

REVISION DATE: 01 FEB 2008

SUPERCEDES REVISION DATED:

REVISION NUMBER: 1

REVISION SUMMARY: INITIAL ENTRY

KEY:
NE = NOT ESTABLISHED
NA = NOT APPLICABLE
(R) = REGISTERED TRADEMARK

ARKEMA INC. BELIEVES THAT THE INFORMATION AND RECOMMENDATIONS CONTAINED
HEREIN (INCLUDING DATA AND STATEMENTS) ARE ACCURATE AS OF THE DATE HEREOF.
NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF
MERCHANTABILITY, OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE
CONCERNING THE INFORMATION PROVIDED HEREIN. THE INFORMATION PROVIDED
HEREIN RELATES ONLY TO THE SPECIFIC PRODUCT DESIGNATED AND MAY NOT BE
VALID WHERE SUCH PRODUCT IS USED IN COMBINATION WITH ANY OTHER MATERIALS
OR IN ANY PROCESS. FURTHER, SINCE THE CONDITIONS AND METHODS OF USE ARE
BEYOND THE CONTROL OF ARKEMA INC., ARKEMA INC. EXPRESSLY DISCLAIMS ANY AND
ALL LIABILITY AS TO ANY RESULTS OBTAINED OR ARISING FROM ANY USE OF THE
PRODUCT OR RELIANCE ON SUCH INFORMATION.

PRODUCT CODE: 04608

ISSUED: 01 FEB 2008